Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features allow for selective binding to specific enzyme active sites, enhancing drug efficacy and reducing off-target effects. Commonly employed in the preparation of investigational oncology compounds due to its metabolic stability and favorable pharmacokinetic profile. Also utilized in asymmetric synthesis to introduce chirality in active pharmaceutical ingredients (APIs), improving enantiomeric purity and biological activity.